1. Home
  2. Advent

Category: KaNDy

Advent Life Sciences seals KaNDy sale to industry giant Bayer, deal could be worth over $975m

Europe's Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.